Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions-Reference-Cited by-同舟云学术

Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions

Published:2012-11-09 Issue:1 Volume:5 Page:74-86
ISSN:1757-9708
Container-title:Integrative Biology
language:en
Short-container-title:

Author:

Bradbury Michelle S.¹,Phillips Evan¹,Montero Pablo H.²,Cheal Sarah M.¹,Stambuk Hilda¹,Durack Jeremy C.¹,Sofocleous Constantinos T.¹,Meester Richard J. C.³,Wiesner Ulrich⁴,Patel Snehal²

Affiliation:

1. Department of Radiology, Sloan Kettering Institute for Cancer Research, 1275 York Ave., Z-2001, New York, NY 10065, USA. Fax: +1 (646)-888-3059; Tel: +1 (646)-888-3373

2. Department of Surgery, Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA

3. Quest Medical Imaging B.V., Middenmeer, The Netherlands NL-1775PW

4. Department of Materials Science & Engineering, 330 Bard Hall, Cornell University, Ithaca, NY 14853, USA

Publisher

Oxford University Press (OUP)

Subject

Biochemistry,Biophysics

Link

http://academic.oup.com/ib/article-pdf/5/1/74/27442317/c2ib20174g.pdf

Reference63 articles.

1. Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.;Balch;J. Clin. Oncol.,2001

2. Molecular imaging in cancer;Weissleder;Science,2006